PEPG Q3 2022 Earnings — PepGen Inc. Revenue & Financial Results | Market Cap Arena

PEPGPepGen Inc.

$435M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$20M

Net Income

-$19M

EPS (Diluted)

$-0.79

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$208M

Total Liabilities

$16M

Stockholders' Equity

$193M

Cash & Equivalents

$196M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$20M	-$8M	-142.1%
Net Income	-$19M	-$8M	-129.4%